# Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

> **NCT04085887** · PHASE1,PHASE2 · RECRUITING · sponsor: **Stanford University** · enrollment: 12 (estimated)

## Conditions studied

- Brain Tumor

## Interventions

- **DRUG:** Panitumumab-IRDye800
- **DEVICE:** Pinpoint-IR9000 endoscopic/handheld device
- **DEVICE:** Explorer Air camera
- **DEVICE:** PDE-NEO-II

## Key facts

- **NCT ID:** NCT04085887
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04085887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04085887, "Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04085887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*